Scott Tarriff - 28 Feb 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Scott Tarriff
Issuer symbol: EGRX
Transactions as of: 28 Feb 2023
Net transactions value: -$87,164
Form type: 4
Filing time: 02 Mar 2023, 15:18:53 UTC
Previous filing: 24 Jan 2023
Next filing: 15 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EGRX	Common Stock	Tax liability	$87,164	-3,113	-0.2%	$28.00	1,569,034	28 Feb 2023	Direct	F1
transaction	EGRX	Common Stock	Award	$0	+70,900	+4.5%	$0.000000	1,639,934	01 Mar 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.
F2	Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of March 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Content

The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.

Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of March 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.